logo
Select company
Select metric
$ -7.79MEarning Before Interest & Taxes (EBIT)
VS
Market
32
Sector
68
Industry
83
History
65
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -7.79M
3/31/2025$ -7.95M
12/31/2024$ -7.55M
9/30/2024$ -6.81M
6/30/2024$ -7.67M
3/31/2024$ -6.07M
12/31/2023$ -6.35M
9/30/2023$ -6.97M
6/30/2023$ -7.93M
3/31/2023$ -15.47M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -9.84M.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average EBIT has been $ -10.82M.
  • The median EBIT for INMED PHARMACEUTICALS INC during this period was $ -7.95M
  • INMED PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -6.07M.
  • The lowest EBIT recorded by INMED PHARMACEUTICALS INC in the same timeframe $ -19.13M

INMED PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
NBY : NOVABAY PHARMACEUTICALS INC $ 3.32MXBIO : XENETIC BIOSCIENCES INC $ -3.08MSPRB : SPRUCE BIOSCIENCES INC $ -46.1MCPHI : CHINA PHARMA HOLDINGS INC $ -3.54MONCO : ONCONETIX INC $ -44.08MSXTP : 60 DEGREES PHARMACEUTICALS INC $ -7.81MBNBX : APPLIED DNA SCIENCES INC $ -13.19MADTX : ADITXT INC $ -30.23MCDT : CONDUIT PHARMACEUTICALS INC $ -18.15MGTBP : GT BIOPHARMA INC $ -9.39M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

INM - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -19.13M

Minimum

Sep 30, 2022

$ -6.07M

Maximum

Mar 31, 2024

$ -10.82M

Average

$ -7.95M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M